Compare AbCellera Biologics Inc (ABCL) vs Conagra Brands Inc (CAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Conagra Brands Inc — how do they compare? AbCellera Biologics Inc trades at $8.95 (market cap $2.99B), while Conagra Brands Inc trades at $14.93 (market cap $7.14B). The key difference: Conagra Brands Inc is far larger — about 2.4× AbCellera Biologics Inc's market cap, and Conagra Brands Inc pays a 8.2% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | CAG | |
|---|---|---|
Market Cap | $2.99B | $7.14B |
Sector | Health | Consumer Staples |
52-Week High | $9.76 | $20.02 |
52-Week Low | $2.78 | $12.58 |
Enterprise Value | $2.58B | $14.20B |
Dividend Yield | — | 8.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Conagra Brands Inc
Conagra Brands is a packaged food company that operates predominantly in the United States (over 90% of revenue and profits). It has a significant presence in the freezer aisle, with brands such as Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Other popular brands include Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. While the majority of revenue is sold into the U.S. retail channel, 9% of fiscal 2022 sales were to the food-service channel, down from 11% in fiscal 2019 due to the pandemic.
Read more on CAG →
